BR112017021631A2 - composto, composição farmacêutica, combinação farmacêutica, método de tratamento, uso de um composto e processo para preparação de dito composto - Google Patents

composto, composição farmacêutica, combinação farmacêutica, método de tratamento, uso de um composto e processo para preparação de dito composto

Info

Publication number
BR112017021631A2
BR112017021631A2 BR112017021631-0A BR112017021631A BR112017021631A2 BR 112017021631 A2 BR112017021631 A2 BR 112017021631A2 BR 112017021631 A BR112017021631 A BR 112017021631A BR 112017021631 A2 BR112017021631 A2 BR 112017021631A2
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
preparing
treatment
compounds
Prior art date
Application number
BR112017021631-0A
Other languages
English (en)
Inventor
Dutt Chaitanya
Chandra Gupta Ramesh
Patel Manish
Abraham Jaya
Mishra Vivek
Kesarwani Amit
Deshpande Shailesh
Kumar Zambad Shital
Mathur Anoop
Kotecha Jignesh
Latad Sachin
Chaudhari Anita
Original Assignee
Torrent Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Limited filed Critical Torrent Pharmaceuticals Limited
Publication of BR112017021631A2 publication Critical patent/BR112017021631A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126—Acids containing more than four carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

a presente invenção refere-se a novos compostos de piridínio, seus isômeros, esterômeros, atropisômeros, conformadores, tautômeros, polimorfos, hidratos e solvatos. o presente invento engloba também um processo para a preparação de novos compostos, e uma composição farmacêutica dos referidos compostos. a invenção refere-se ainda à utilização dos compostos acima mencionados para a preparação de um medicamento para uso como produtos farmacêuticos.
BR112017021631-0A 2015-04-08 2016-04-05 composto, composição farmacêutica, combinação farmacêutica, método de tratamento, uso de um composto e processo para preparação de dito composto BR112017021631A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1473MU2015 2015-04-08
IN1473/MUM/2015 2015-04-08
PCT/IB2016/051917 WO2016162785A1 (en) 2015-04-08 2016-04-05 Novel pyridinium compounds

Publications (1)

Publication Number Publication Date
BR112017021631A2 true BR112017021631A2 (pt) 2018-07-03

Family

ID=55808799

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017021631-0A BR112017021631A2 (pt) 2015-04-08 2016-04-05 composto, composição farmacêutica, combinação farmacêutica, método de tratamento, uso de um composto e processo para preparação de dito composto

Country Status (19)

Country Link
US (2) US10233175B2 (pt)
EP (1) EP3280711A1 (pt)
JP (1) JP6782763B2 (pt)
KR (1) KR20170134661A (pt)
CN (1) CN107438604B (pt)
AR (1) AR104274A1 (pt)
AU (1) AU2016245418B2 (pt)
BR (1) BR112017021631A2 (pt)
CA (1) CA2997364A1 (pt)
EA (1) EA035406B1 (pt)
IL (1) IL254792B (pt)
MX (1) MX2017012943A (pt)
MY (1) MY182914A (pt)
PH (1) PH12017501830A1 (pt)
SG (1) SG11201708140RA (pt)
TW (1) TWI710559B (pt)
UA (1) UA120389C2 (pt)
WO (1) WO2016162785A1 (pt)
ZA (1) ZA201707090B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2997364A1 (en) * 2015-04-08 2016-10-13 Torrent Pharmaceuticals Limited Novel pyridinium compounds
LT3762368T (lt) 2018-03-08 2022-06-10 Incyte Corporation Aminopirazindiolio junginiai, kaip pi3k-γ inhibitoriai
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
US20200338058A1 (en) * 2019-04-28 2020-10-29 King Faisal University Therapeutic agents for treating and preventing autoimmune diseases and cancer and a screening method
WO2022238921A1 (en) * 2021-05-14 2022-11-17 Torrent Pharmaceuticals Limited In-situ synthesis of 3-substituted pyridinium compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2215000C2 (ru) * 1999-10-06 2003-10-27 Торрент Фармасьютикалз Лтд. Производные солей пиридиния, способ их получения, фармацевтические композиции на их основе и способы лечения
PL348049A1 (en) * 1999-10-06 2002-05-06 Torrent Pharmaceuticals Ltd Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications
US6608094B2 (en) * 1999-10-06 2003-08-19 Torrent Pharmaceuticals Ltd. Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
DK1243581T3 (da) 2001-03-21 2005-10-31 Torrent Pharmaceuticals Ltd Pyridiniumforbindelser til behandling af AGE-relaterede sygdomme
PT1373263E (pt) 2001-04-05 2005-03-31 Torrent Pharmaceuticals Ltd Compostos heterociclicos para complicacoes relacionadas com a idade e complicacoes vasculares diabeticas
EP1996588A4 (en) 2006-03-03 2011-10-05 Torrent Pharmaceuticals Ltd NEW DUAL ACTION RECEPTOR (DARA) ANTAGONISTS OF ATI AND ETA RECEPTORS
CA2997364A1 (en) * 2015-04-08 2016-10-13 Torrent Pharmaceuticals Limited Novel pyridinium compounds

Also Published As

Publication number Publication date
AR104274A1 (es) 2017-07-12
IL254792A0 (en) 2017-12-31
KR20170134661A (ko) 2017-12-06
CA2997364A1 (en) 2016-10-13
TW201639834A (zh) 2016-11-16
CN107438604B (zh) 2021-12-03
US10717727B2 (en) 2020-07-21
EA035406B1 (ru) 2020-06-09
US20190169175A1 (en) 2019-06-06
AU2016245418B2 (en) 2020-03-26
UA120389C2 (uk) 2019-11-25
WO2016162785A1 (en) 2016-10-13
JP2018511658A (ja) 2018-04-26
EP3280711A1 (en) 2018-02-14
MX2017012943A (es) 2018-01-30
MY182914A (en) 2021-02-05
JP6782763B2 (ja) 2020-11-11
US20180118728A1 (en) 2018-05-03
EA201792234A1 (ru) 2018-02-28
AU2016245418A1 (en) 2017-11-02
TWI710559B (zh) 2020-11-21
SG11201708140RA (en) 2017-11-29
PH12017501830A1 (en) 2018-04-23
US10233175B2 (en) 2019-03-19
CN107438604A (zh) 2017-12-05
ZA201707090B (en) 2021-03-31
IL254792B (en) 2021-01-31

Similar Documents

Publication Publication Date Title
BR112018005497A2 (pt) compostos heterocíclicos e usos dos mesmos
CL2018000542A1 (es) Nuevos derivados de fenoximetilo.
CL2018002009A1 (es) Compuestos derivados de ciclopentanoperhidofenantreno, moduladores de fxr; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento de enfermedades colestásicas, fibróticas, hipercolesterolemia, entre otras.
BR112017022604A2 (pt) composto, composição farmacêutica, uso de um composto e de uma combinação, e, combinação
BR112017010354B8 (pt) Compostos de triazolopirimidina, seu uso, e composição farmacêutica
MX2018004175A (es) Derivado oxa espiro, su metodo de preparacion, y sus aplicaciones en medicinas.
CL2015001733A1 (es) Compuestos derivados de lactamas fusionadas de arilo y heteroarilo, moduladores de ezh2; composicion farmaceutica que los comprende; uso del compuesto para el tratamiento del cancer.
BR112014021531A8 (pt) composto, composição farmacêutica e usos dos mesmos
BR112016023558A2 (pt) compostos úteis como imunomoduladores
PH12017500416A1 (en) Compounds and compositions as raf kinase inhibitors
BR112014012878A8 (pt) composto, uso de um composto, composição farmacêutica e processos de fabricação de um composto
BR112016014020A8 (pt) moduladores de tetra-hidropiridopirazinas de gpr6.
CL2014000311A1 (es) Compuestos derivados de benzotiazepinas sustituidas; composicion farmaceutica que los contiene; y su uso para el tratamiento o profilaxis de la infeccion del virus sincicial respiratorio.
BR112014018990A8 (pt) Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção
CL2014000543A1 (es) Compuestos derivados de imidazopiridazinas sustituidas con amino, inhibidores de la quinasa ,mknk2; metodo de preparacion; compuestos intermediarios y su uso; composicion farmaceutica; combinacion farmaceutica; y su uso para el tratamiento del cancer.
MX2017014035A (es) Formas solidas novedosas.
BR112017021631A2 (pt) composto, composição farmacêutica, combinação farmacêutica, método de tratamento, uso de um composto e processo para preparação de dito composto
MX364376B (es) Derivado de fenol y metodo de preparacion y uso en la medicina del mismo.
BR112018070123A2 (pt) oxiesterós e métodos de uso dos mesmos
BR112017004173A2 (pt) composto, composição farmacêutica, e, método para tratar uma doença ou condição patológica.
BR112017010311A2 (pt) 4-oxo-3,4-dihidro-1,2,3-benzotriazinas como moduladores de gpr139
EA201790949A1 (ru) Замещенные 2,4-диаминохинолины в качестве новых противораковых средств
BR112017005242A2 (pt) composto, composição farmacêutica, e, composto para uso.
CL2014002845A1 (es) Compuestos derivados de pirazol inhibidores de sglt1; metodo para tratar la diabetes; composicion farmaceutica; uso del compuesto para el tratamiento de la diabetes tipo 1 y tipo 2.
BR112017002852A2 (pt) compostos de azetidiniloxifenilpirrolidina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements